The deficiency in Scd1 has been reported to confer protection from steatosis, reflecting a decrease in lipogenic rates and an increase in β-oxidation pathway activation (Gutierrez-Juarez et al., 2006; Miyazaki et al., 2007). This evidence concerns the gene SCD and steatosis.